Literature DB >> 21099215

Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.

William J Savage1, Allen D Everett, James F Casella.   

Abstract

A 12-year-old boy with HbSS sickle cell disease (SCD) was admitted with an acute febrile illness and developed overt stroke 3 days later. Plasma glial fibrillary acidic protein levels were elevated, as compared to pediatric controls, 32 h prior to the clinical diagnosis of stroke, peaked immediately prior to the exchange transfusion, and remained elevated 1 year later despite chronic transfusion therapy. Stroke in SCD can occur in the setting of acute illness, and a biomarker that could predict the onset and triage ill children to therapeutic intervention more quickly would be useful.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099215      PMCID: PMC3202928          DOI: 10.1159/000321791

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  17 in total

1.  Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke.

Authors:  M T Wunderlich; C W Wallesch; M Goertler
Journal:  Eur J Neurol       Date:  2006-10       Impact factor: 6.089

2.  Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

Authors:  Linda E Pelinka; Alfred Kroepfl; R Schmidhammer; Manfred Krenn; Walter Buchinger; Heinz Redl; Andreas Raabe
Journal:  J Trauma       Date:  2004-11

3.  Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Authors:  Robert J Adams; Donald Brambilla
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

4.  Serum GFAP is a diagnostic marker for glioblastoma multiforme.

Authors:  C S Jung; C Foerch; A Schänzer; A Heck; K H Plate; V Seifert; H Steinmetz; A Raabe; M Sitzer
Journal:  Brain       Date:  2007-11-12       Impact factor: 13.501

5.  Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Authors:  P E Vos; K J B Lamers; J C M Hendriks; M van Haaren; T Beems; C Zimmerman; W van Geel; H de Reus; J Biert; M M Verbeek
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

6.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

7.  Neurological injury markers in children with septic shock.

Authors:  Angela A Hsu; Kimberly Fenton; Steven Weinstein; Jessica Carpenter; Heidi Dalton; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2008-05       Impact factor: 3.624

8.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

9.  Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.

Authors:  Gustaf Osterlundh; Ingemar Kjellmer; Birgitta Lannering; Lars Rosengren; Ulf A Nilsson; Ildikó Márky
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

10.  Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants?

Authors:  M Blennow; H Hagberg; L Rosengren
Journal:  Pediatr Res       Date:  1995-03       Impact factor: 3.756

View more
  8 in total

Review 1.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

2.  Shoulder surgery in the beach chair position is associated with diminished cerebral autoregulation but no differences in postoperative cognition or brain injury biomarker levels compared with supine positioning: the anesthesia patient safety foundation beach chair study.

Authors:  Andrew Laflam; Brijen Joshi; Kenneth Brady; Gayane Yenokyan; Charles Brown; Allen Everett; Ola Selnes; Edward McFarland; Charles W Hogue
Journal:  Anesth Analg       Date:  2015-01       Impact factor: 5.108

Review 3.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

Review 4.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Glial fibrillary acidic protein as a biomarker for brain injury in neonatal CHD.

Authors:  Stephanie L McKenney; Fahad F Mansouri; Allen D Everett; Ernest M Graham; Irina Burd; Priya Sekar
Journal:  Cardiol Young       Date:  2016-01-20       Impact factor: 1.093

6.  Rewarming Rate During Cardiopulmonary Bypass Is Associated With Release of Glial Fibrillary Acidic Protein.

Authors:  Daijiro Hori; Allen D Everett; Jennifer K Lee; Masahiro Ono; Charles H Brown; Ashish S Shah; Kaushik Mandal; Joel E Price; Laeben C Lester; Charles W Hogue
Journal:  Ann Thorac Surg       Date:  2015-07-07       Impact factor: 4.330

7.  Evidence of an association between brain cellular injury and cognitive decline after non-cardiac surgery.

Authors:  T Rappold; A Laflam; D Hori; C Brown; J Brandt; C D Mintz; F Sieber; A Gottschalk; G Yenokyan; A Everett; C W Hogue
Journal:  Br J Anaesth       Date:  2016-01       Impact factor: 9.166

8.  Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.

Authors:  Eboni I Lance; Lisa M Faulcon; Zongming Fu; Jun Yang; Donna Whyte-Stewart; John J Strouse; Emily Barron-Casella; Kimberly Jones; Jennifer E Van Eyk; James F Casella; Allen D Everett
Journal:  Proteomics Clin Appl       Date:  2021-05-24       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.